Dr. Honghong Zhu | Colorectal Cancer | Best Researcher Award

Dr. Honghong Zhu | Colorectal Cancer | Best Researcher Award

Zhejiang Chinese Medical University | China

Author Profile

Scopus

Biography of Hong-Hong Zhu, MD, MSc, PhD – Professor of Extraordinary Ability 🎓🌍

🎯 Current Role: Leader in Medical Research

Dr. Hong-Hong Zhu is the Head of the Center for Medical Research at Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (Quzhou Hospital of TCM). Her leadership in medical research spans over three decades.

📜 Educational Background

  • Ph.D. in Epidemiology from Johns Hopkins University (JHU) Bloomberg School of Public Health (2007)
  • Postdoctoral Training at the U.S. National Institutes of Health (NIH)
  • MD & Master’s Degree in Medicine from Zhejiang University
  • M.Sc. from Clemson University

💡 Key Contributions: Breast Cancer Etiology Pioneer

Dr. Zhu was the first to propose the Synergistic Interaction Theory for breast cancer, linking environmental carcinogens and exogenous hormone use. Her work has significantly advanced the understanding of cancer causes.

🔬 Innovator in Colorectal Cancer Prevention

With 32 years of research in colorectal cancer prevention, Dr. Zhu and her team developed cost-effective screening methods that have saved millions of lives worldwide.

🏆 Academic Achievements and Awards

  • 135 Publications in esteemed journals
  • 35 Awards, including:
    • Best Poster Award (NIH) for breast cancer research (2006)
    • Delta Omega Honor from the U.S. National Public Health Honor Society (2007)
    • Second Place in Scientific Competition in Epidemiology and Public Health (2007)
    • Professor of Extraordinary Ability (2015)
    • Sigma Xi Scientific Research Honor (2024)

📚 Editor and Peer Reviewer

  • Editor-in-Chief of the Journal of GHR (since 2015)
  • Peer Reviewer for academic journals for over 20 years
  • Grant Reviewer for the U.S. Department of Health and Human Services (12 years)

Dr. Hong-Hong Zhu’s contributions to medical research have made her a global figure in epidemiology and cancer prevention.

🔍 Conclusion

With over three decades of research in epidemiology and disease prevention, Dr. Hong-Hong Zhu has made groundbreaking contributions in breast and colorectal cancer research. Her innovative approaches to cancer screening and prevention have been life-saving on a global scale. She remains a recognized leader in public health, continuing to inspire through her research, publications, and numerous honors. 🌟

 

📊🔬NOTABLE PUBLICATION:

 

  • Combining FITs and HRFQ with colonoscopy improve the cost-effectiveness of a 9-year mass colorectal cancer screening program
    Authors: Cai, S.-R., Huang, Y.-Q., Li, Q.-R., Yang, J.-H., Zheng, S.
    Journal: ESMO Open
    Year: 2024

 

  • Sex difference in alcohol consumption associated with colorectal cancer risk in Quzhou, China: A nested case-control study
    Authors: Lai, S.-M., Zhu, H.-H., Gan, Z.-J., Wang, Z.-C., Liao, X.-F.
    Journal: Preventive Medicine Reports
    Year: 2024

 

  • Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years
    Authors: Zhu, H.-H., Sun, G.-Q., Wu, J.-Y., Wang, Z.-C., Liao, X.-F.
    Journal: Frontiers in Immunology
    Year: 2023

Mr. Yang Gao | Cholangiocarcinoma | Best Researcher Award

Mr. Yang Gao | Cholangiocarcinoma | Best Researcher Award

Tongji Medical College Huazhong University of Science and Technology | China

Author Profile

Scopus

📘 Dr. Yang Gao: A Dedicated Leader in Hepatobiliary Oncology Research

Full Name: Yang Gao

Gender: Male

Designation: Attending Doctor; Lecturer

Department: Department of Hepatobiliary Surgery

Institution/Organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Qualification: Doctor (MD, PhD)

Area of Specialization: Hepatobiliary Oncology and Cancer

Sub Division: Oncology Therapeutics and Novel Approaches

Date of Birth: October 25, 1987

Onboard Date: July 1, 2018

Total Experience:

  • Work: 5 years
  • Doctor: 3 years
  • Master: 3 years
  • Bachelor: 5 years

Contact Information:

🎓 Education and Training

  • 2015.09-2018.06: MD, PhD in Hepatobiliary Surgery from Tongji Medical College, Huazhong University of Science and Technology
  • 2012.09-2015.06: Master’s in Hepatobiliary Surgery from Tongji Medical College, Huazhong University of Science and Technology
  • 2007.09-2012.06: Bachelor’s in Clinical Medicine from Shandong Second Medical University

🏥 Professional Experience

2018.07 – Present: Attending Physician and Lecturer at the Affiliated Union Hospital of Tongji Medical College, Huazhong University of Science and Technology.

  • Proficient in surgical treatments for benign and malignant tumors of the liver and gallbladder, including gallstones.
  • Expert in minimally invasive laparoscopic surgery, especially for liver cancer, anatomical liver resection surgery, and complex biliary surgeries.
  • Skilled in the comprehensive treatment of hepatocellular carcinoma and biliary tract cancer, including intervention, targeting, and immunotherapy.

📊 Research, Innovations, and Extensions

  • Research Projects Completed and Ongoing: 6
  • Citation Index in Scopus/Web of Science/PubMed: 61
  • Total Project Cost: $414,000 USD
  • Patents: 5 published and under process
  • Journals Published (SCI and SCIE index): 12
  • Journals Published (Scopus/Web of Science/PubMed index): 13
  • Countries Visited for Research: 1
  • Cumulative Impact Factor (last 3 years): 55
  • H-index: 5
  • Invited Speaker/Resource Person: 1
  • Member of Professional Bodies: 10

🏆 Awards and Recognitions

  • Total Number of Awards and Recognitions: 1
  • Award Category: Best Researcher Award

🌐 Contribution to Research & Development, Innovations, and Extension Activities On Cholangiocarcinoma

Dr. Yang Gao has significantly contributed to the field of Tumor Research & Development, Innovations, and Extension Activities. His work focuses on advancing the understanding of tumor biology, therapeutic interventions, and patient care outcomes, particularly in hepatobiliary malignancies. Dr. Gao collaborates with interdisciplinary teams to discover novel biomarkers, therapeutic targets, and treatment modalities aimed at improving patient outcomes and quality of life.

Dr. Gao has played a pivotal role in translating research findings into clinical practice by fostering partnerships with industry stakeholders, academic institutions, and healthcare providers. His efforts have led to the development and implementation of cutting-edge technologies and treatment approaches in oncology.

Moreover, Dr. Gao actively engages in extension activities to disseminate knowledge and promote cancer prevention, early detection, and treatment options within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with the information and resources needed to combat cancer effectively. His dedication to cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

📜 Personal and Research Proofs

  • Institute ID Number: 2018XH0171
  • Certificate Number (Education Proof): 1048722018100647
  • Passport Number: E28938966
  • Government ID: 370181198710251116

Declaration

Dr. Yang Gao, authenticate that to the best of my knowledge, the information given in this form is correct and complete. If any material information is found to be concealed, my application shall be summarily terminated without notice. I have read and agree to the terms and conditions and other policies of the International Research Awards.

Notable Publication

    • Authors: Yang Gao, et al.
    • Journal: Journal of Hepatology Research
    • Volume: 35
    • Year: 2021

 

 

    • Authors: Yang Gao, et al.
    • Journal: Cancer Research
    • Volume: 80
    • Year: 2022

 

    • Authors: Yang Gao, et al.
    • Journal: Annals of Surgery
    • Volume: 270
    • Year: 2021

 

    • Authors: Yang Gao, et al.
    • Journal: International Journal of Surgery
    • Volume: 76
    • Year: 2020